LabCorp Clinical Trials, A LabCorp Company
- Global Manager Scientific Affairs
2013 - maintenant
LabCorp Clinical Trials, A LabCorp Company
- Scientific Affairs Manager
2011 - maintenant
Clearstone Central Laboratories, A LabCorp Company
- R&D Manager, Assay Validation & Development
2010 - 2011• Manage Global R&D Lab Technologists and Engineer (China, Canada, Singapore, France);
• Define and manage the resources necessary for the implementation of the objectives;
• Global lead for the validation & development of over 20 new assays including esoteric, biomarker and routine tests on automated platforms
(ETI-Max 3000, Modular P, Immulite 2000, AxSym, SpectraMax Plus 384);
• Lead the technology transfer over 50 assays (immunoassays, biochemistry, hemostase);
• Play a key role in the establishment of fit-for-purpose assay validation process with plate-based and bead-based immunoassays
• Lead the scientific preparation/review of all documentation related to assay validation
(plan, report, biomarker checklist, raw data, SOPs);
• Provide recommendations of acceptance criteria for in-study testing;
• Act as liaison with other Department to ensure sponsor satisfaction;
• Proceed to structural reorganization of the R&D Lab.
Clearstone Central Laboratories
- Quality Engineer (QC Lab Specialist)
Paris2007 - 2010• Led the follow up of internal quality controls for esoteric and biomarker testing;
• Implementation of quality system (QC follow up);
• Led semi-annual instrument-to-instrument comparison; over 250 tests
(biochemistry, haematology, hemostase, immuno-assays and flow cytometry);
• Participated to laboratory internal/external audit;
• Played a key role in the preparation of the CAP accreditation and self-accreditation;
• Ensured and followed up external Proficiency Testing program and Quality Controls(CAP, NGSP, CDC Lipid);
• Prepared or reviewed SOPs; trained lab technologists.
(start-up)
- Start-up creation project
2006 - 2006• Scientific review for marketing study;
• Business plan elaboration;
• Presentation to academic and private investors and partners.
Synth'E163 - Strasbourg
- Research Engineer
2002 - 2005• Synthesis of over 250 molecules exhibiting antibacterial and antifungal properties;
• Development of a structure-activity relationship drug libraries (antimicrobial/antiviral);
• Optimization of properties, activity, stability;
• Identification of 2 leads;
• Raising of 300K€ capital with private investors and business angels.
Laboratoire de Physiopathologie et d'antibiologie microbienne - Strasbourg
- Research Engineer
2001 - 2001Development and Validation of an HPLC method for a new molecule against S. aureus.
